- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefTM
- Patient Resources
Significant racial disparities exist between Black and White Americans in need of kidney transplantation. This healthcare disparity is multifactorial including limited kidney donors for Black Americans, inconsistent care coordination, social determinants of health, reduced access to care, and mistrust of clinicians and the healthcare system.1 Join us for an informative panel discussion as we discuss these challenges and possible solutions to bridge these disparities.
- Harding K, Mersha T, B, Pham P, -T, Waterman A, D, Webb F, J, Vassalotti J, A, Nicholas S, B: Health Disparities in Kidney Transplantation for African Americans. Am J Nephrol 2017;46:165-175. doi: 10.1159/000479480
*Dr Richard Knight, Dr Lisa McElroy, and Ms Amy Kozsuch are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Sahar Salehi is an employee of OPDC.
President of American Association of Kidney Patients (AAKP)*
Richard A Knight is President of the American Association of Kidney Patients (AAKP), which is the oldest and largest, independent kidney patient organization in the United States. He is also a former hemodialysis patient and received a kidney transplant approximately fourteen years ago. Mr Knight has a background in public policy and Congressional operations based on both his professional experience on Capitol Hill where he served in various roles including communications, policy and Legislative Director as well his advocacy work as a kidney transplant patient. While working in the United States House of Representatives, Mr Knight served as a liaison to the Congressional Black Caucus for his Member of Congress. His knowledge of Executive Branch agency budget and procurement policies is based on direct experience as a Federal government contractor and as a ten-year co-chair of the Baltimore Washington Corridor Chamber of Commerce Annual Regional Government Procurement Fair. Mr Knight received his MBA from the University of Virginia Darden School of Business and his BA from Hampton University. He is a business strategist, providing patient engagement consulting for healthcare organizations and businesses developing tools designed to leverage patient input and preferences in their care plans and quality measures. As a small business owner, he is heavily involved in business and education issues through multiple executive networks in the Washington, DC region. He serves as adjunct professor at Bowie State University (BSU). He is a founding member of BSU’s College of Business Advisory Council.
Duke University School of Medicine*
Dr Lisa McElroy is an Assistant Professor of Abdominal Transplant Surgery at Duke University. She received her MD from Michigan State University and a Master of Science in Health Services and Outcomes Research from Northwestern University. She completed her clinical fellowship in abdominal transplant surgery at the University of Michigan. Her research examines the influence of organizational and health system characteristics on clinical outcomes of high cost, high acuity patients and her long-term interests are in the dissemination of best practices in transplant surgery and improving the quality and equity of transplant care for underrepresented and disadvantaged populations with end stage organ disease. Her work is funded by the Duke Center for Research to Advance Healthcare Equity and the Robert Wood Johnson Foundation. She is also a 2020 American Journal of Transplantation Editorial Fellow.
Health Map Solutions*
Amy Kozsuch is the Vice President of Clinical Products at Healthmap. In this role she is responsible for expanding and developing innovative programs that advance early detection of chronic kidney disease, defer its progression, and deliver improved patient outcomes at lower costs. Amy has 30 years of experience in the kidney health industry, having worked as a nurse administrator, director of clinical operations and corporate development in the past. She serves on several health industry board of directors, most recently as executive board president for the National Kidney Foundation of Florida. Amy earned her MSN, MBA, and Health Care Administration degrees from University of Phoenix, where she is currently a doctoral candidate.
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Sahar Salehi, PhD, is a Medical Science Liaison for Otsuka covering the Southern California and Hawaii regions. She has three and a half years of experience as a medical science liaison in multiple therapeutic areas including Dermatology, Gastroenterology, Rheumatology, and Nephrology. Sahar earned her PhD in transplant immunology from University of California Los Angeles, where her research focused on antibody-mediated rejection in cardiac and renal transplantation. Following completion of her PhD, she spent 6 months conducting clinical research at UCLA before moving into Medical Affairs within the biopharmaceutical industry.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.May 2020 MRC2.CORP.X.04767
January 31 from 12:00 pm to 1:00 pm
February 14 from 12:00 pm to 1:00 pm
- Resource Center
- Patient Resources